Background HPV16/18 detection may improve cervical cancer risk stratification and better
guide which HPV-positive women warrant immediate colposcopy/biopsy. We estimated risks …

Whereas HPV16 and HPV18 have been the focus in current risk‐based cervical cancer
screening algorithms using HPV genotype information, mounting evidence suggests that …

The Canadian Cervical Cancer Screening Trial was a randomized controlled trial comparing
the performance of human papillomavirus (HPV) testing and Papanicolaou cytology to …

Abstract Background: The cobas HPV Test (“cobas”; Roche Molecular Systems) detects
HPV16 and HPV18 individually, and a pool of 12 other high-risk (HR) HPV types. The test is …

Objective We assessed the age-related prevalence of high risk human papillomavirus (HR-
HPV) genotypes and the genotype-associated risk for high-grade cervical intraepithelial …

Background: Primary high-risk human papillomavirus (hr-HPV) testing of self-collected
cervico-vaginal swabs could increase cervical cancer screening coverage, although triage …

Objective Thirteen human papillomavirus (HPV) genotypes are associated with the highest
risk of cervical disease/cancer; however, the risk of disease progression and cancer is …

Objectives The objective of the present study is to assess the performance of a high-risk
human papillomavirus (HR-HPV) DNA test with individual HPV-16/HPV-18 genotyping as a …

HPV testing is more sensitive than cytology for cervical screening. However, to incorporate
HPV tests into screening, risk‐stratification (“triage”) of HPV‐positive women is needed to …

Introduction Human papillomavirus (HPV) testing as the primary cervical cancer screening
method is implemented in several countries. We report data from the first round of a large …